rosiglitazone has been researched along with Colorectal Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrigel, DJ; Moss, RA | 1 |
| Brodsky, AS; Friedman, K; Gill, AJ; Karashchuk, G; Lombardo, K; Lu, S; Resnick, MB; Wood, SM; Yang, D | 1 |
| Chen, J; Chen, W; Cheng, Q; Jiang, H; Miao, C; Ren, Y; Sun, Z; Wang, H; Weng, M; Wu, Q; Xu, P; Xu, Y; Zhong, J; Zhu, M | 1 |
| Chiu, SJ; Chuah, JQ; Hsaio, CH; Lee, JW; Shih, WL; Su, YH; Tseng, HH | 1 |
| Bingham, V; Campbell, FC; Deevi, RK; Fatehullah, A; Jagan, I | 1 |
| Baldwin, GS; Ford, J; Lachal, S; Shulkes, A | 1 |
| Bai, X; Chen, WC; Lin, MS | 1 |
| Blay, J; Richard, CL | 1 |
| Bai, X; Chen, WC; Lin, MS; Wang, YD | 1 |
| Baek, SJ; Cekanova, M; Kim, K; Li, X; Yuan, JS | 1 |
| Seed, B | 1 |
| Auwerx, J; Briggs, M; Chen, I; Desreumaux, P; Fruchart, JC; Geboes, K; Heyman, R; Lefebvre, AM; Najib, J | 1 |
| Brockman, JA; Dubois, RN; Gupta, RA | 1 |
| Aaltonen, LA; de la Chapelle, A; Eng, C; Kum, JB; Mueller, E; Sarraf, P; Smith, WM; Spiegelman, BM; Wright, HM | 1 |
| Baek, SJ; Eling, TE; Hsi, LC; Ikawa, H; Kameda, H; Kamitani, H; Nixon, JB | 1 |
1 review(s) available for rosiglitazone and Colorectal Neoplasms
| Article | Year |
|---|---|
Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Diabetes Complications; Humans; Hypoglycemic Agents; Insulin; Liver Neoplasms; Metformin; Non-alcoholic Fatty Liver Disease; Pancreatic Neoplasms; Pioglitazone; Precancerous Conditions; Receptors, Somatomedin; Risk Factors; Rosiglitazone; Thiazolidinediones | 2014 |
14 other study(ies) available for rosiglitazone and Colorectal Neoplasms
| Article | Year |
|---|---|
Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Fatty Acid-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Interferon-gamma; Microsatellite Instability; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Microenvironment | 2017 |
MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
Topics: Adenocarcinoma; Animals; Cell Communication; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Progression; DNA-Binding Proteins; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Staging; Oncogene Proteins; Phenotype; PPAR gamma; RAW 264.7 Cells; Receptors, Cell Surface; RNA Interference; Rosiglitazone; Signal Transduction; STAT6 Transcription Factor; Thiazolidinediones; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment | 2016 |
Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Survival; Colorectal Neoplasms; Combined Modality Therapy; Histones; HT29 Cells; Humans; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation-Sensitizing Agents; Rosiglitazone; Thiazolidinediones; Tumor Suppressor Protein p53 | 2010 |
Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.
Topics: Anilides; Apoptosis; Caco-2 Cells; cdc42 GTP-Binding Protein; Cell Growth Processes; Colorectal Neoplasms; HCT116 Cells; Humans; Ligands; Madin Darby Canine Kidney Cells; Molecular Targeted Therapy; PPAR gamma; PTEN Phosphohydrolase; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection | 2013 |
PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
Topics: Bezafibrate; Cell Proliferation; Clofibrate; Clofibric Acid; Colorectal Neoplasms; Fenofibrate; Fibric Acids; Gastrins; Gemfibrozil; Humans; Hypolipidemic Agents; Ligands; Peroxisome Proliferator-Activated Receptors; Protein Precursors; Pyrimidines; Radioimmunoassay; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2004 |
Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity.
Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; HT29 Cells; Humans; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Monoester Hydrolases; PPAR gamma; Prostaglandin D2; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rosiglitazone; Thiazolidinediones; Tumor Suppressor Proteins; Up-Regulation | 2005 |
Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Pioglitazone; PPAR gamma; Receptors, CXCR4; Rosiglitazone; Thiazolidinediones | 2007 |
Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Humans; Hypoglycemic Agents; Ligands; PPAR gamma; Prostaglandin D2; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2007 |
Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells.
Topics: Colorectal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; PPAR gamma; Prostaglandin D2; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcriptional Activation | 2008 |
PPARgamma and colorectal carcinoma: conflicts in a nuclear family.
Topics: Adenomatous Polyposis Coli; Animals; Chromans; Colorectal Neoplasms; Humans; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
Topics: Adenocarcinoma; Animals; beta Catenin; Chromans; Colorectal Neoplasms; Cyclooxygenase 2; Cytoskeletal Proteins; HT29 Cells; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Troglitazone | 1998 |
Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells.
Topics: Cell Cycle; Cell Division; Colorectal Neoplasms; G1 Phase; Humans; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 1998 |
Loss-of-function mutations in PPAR gamma associated with human colon cancer.
Topics: Amino Acid Substitution; Binding Sites; Chromans; Colorectal Neoplasms; Dimerization; DNA-Binding Proteins; Exons; Genes, Tumor Suppressor; Humans; Hydroxyeicosatetraenoic Acids; Ligands; Linoleic Acids; Linoleic Acids, Conjugated; Mutation; Prostaglandin D2; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone | 1999 |
Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Colorectal Neoplasms; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Isoenzymes; Ligands; Membrane Proteins; Models, Biological; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Receptor Cross-Talk; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |